microRNA-10b: A new marker or the marker of pancreatic ductal adenocarcinoma?

Clinical Cancer Research

Volumn 17, Issue 17, 2011, Pages 5527-5529

  Setoyama, Tetsuro ^a,b   Zhang, Xinna ^a   Natsugoe, Shoji ^b   Calin, George A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GEMCITABINE; MICRORNA; MICRORNA 10B; UNCLASSIFIED DRUG;

ALGORITHM; ASPIRATION BIOPSY; CANCER DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; GENE EXPRESSION; HUMAN; IN SITU HYBRIDIZATION; MORTALITY; NOTE; PANCREAS ADENOCARCINOMA; PATIENT CARE; PRIORITY JOURNAL; TREATMENT RESPONSE;

CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MICRORNAS; PANCREATIC NEOPLASMS;

EID: 80052478946     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1477     Document Type: Note

References (12)

1. Preis M, Gardner TB, Gordon SR, Pipas MJ, Mackenzie TA, Klein EE, et al. microRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res 2011;17:5812-21.
2. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007;110:738-44.
3. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24: 5313-27.
4. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009;9:293-302.
5. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006;25:6202-10.
6. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449: 682-8.
7. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010;285:7986-94.
8. Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, et al. MicroRNA- 10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 2010;101:1997-2004.
9. Moriarty CH, Pursell B, Mercurio AM. miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 2010;285:20541-6.
10. Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications.Am J Gastroenterol 2003;98:2663-8.
11. Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, et al. High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Int J Oncol 2011;38:629-41.
12. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010;28:341-7.